register

News - MedTech & Diagnostics

Another talkfest? NSW Preventive Health Summit faces test of political will

Health Industry Hub | October 6, 2026 |

Six days before the NSW Government’s invitation-only Preventive Health Summit, the state’s major political parties have put competing prevention policies on the record, raising questions about what will happen when the rhetoric gives way to implementation.

The timing of the two events is significant.

The NSW Great Health Debate was held on October 1, bringing NSW Health Minister Ryan Park, Opposition Health leader Sarah Mitchell and Greens Health spokesperson Dr Amanda Cohn together to outline their health priorities ahead of the March 2027 state election.

The invitation-only Preventive Health Summit follows on October 7-9 in Parramatta, bringing together health professionals, academics, policymakers and other stakeholders together to develop a cross-government approach to prevention.

That makes the timing of the two events notable. Political parties have been forced to publicly declare their positions before sector leaders meet to discuss what a future preventive-health framework should look like.

The focus of the Summit is a direct response to the 2025 report of the Inquiry led by the Hon. Justice Richard Beasley, which laid bare the deep structural, funding and governance failures confronting the NSW public health system. The Inquiry spanned 70 hearing days over 18 months and produced 41 recommendations, with Justice Beasley concluding that the system required “significant work” and that responsibility for its shortcomings rested with both state and federal governments.

“The failure to embed prevention in all its forms into the health system despite repeated and evidence-based recommendations to do so is beyond my comprehension,” said Justice Beasley at the time when the report was released.

The central political challenge is straightforward. Prevention requires governments to spend money now for benefits that will not be apparent for years, while hospitals and emergency services require funding immediately.

That tension was evident throughout the Great Health Debate.

Minister Park pointed to the government’s crackdown on illicit tobacco and vaping, saying the growth of illegal retailers and youth vaping remained a major concern. Ms Mitchell highlighted childhood obesity and falling routine vaccination rates, while Dr Cohn argued for a dedicated NSW Preventive Health Agency, saying prevention requires a stronger institutional focus.

The proposals reflect different focus areas and views about how prevention should be governed. The question now is whether those commitments will translate into sustained funding.

The AMA has already put a figure on the table. NSW President Dr Fred Betros called for a dedicated prevention fund of $55 million a year for at least four years, arguing that prevention needs clear funding, timelines and accountability. He warned that the health system cannot continue relying on reactive care while under-investing in measures designed to prevent illness in the first place.

That creates a difficult political calculation for any government. A hospital opening delivers a ribbon-cutting ceremony, a news headline and an immediate result voters can see. Preventing obesity, chronic disease and nicotine addiction offers no equivalent political moment, with the benefits often taking years to emerge.

With the March election approaching, the NSW Government is also under pressure to address immediate hospital performance while developing longer-term reforms. The risk, critics argue, is that prevention becomes the first area squeezed when acute health demands increase.

The Beasley Inquiry has already established that prevention cannot sit solely within the health portfolio. Its recommendations call for preventive health to become a standing whole-of-government priority. That potentially puts responsibility beyond NSW Health. Planning, transport, education, housing, food policy, gambling regulation and environmental policy all influence population health. The Summit is therefore attempting something considerably broader than a conventional health conference.

But a cross-government approach also creates an accountability gap. If responsibility is spread across departments, who is ultimately accountable for funding decisions and missed targets?

With the March 2027 election looming, the Summit comes at a politically critical time. NSW Health will prepare a report for government, but there is no guaranteed funding, targets or implementation timetable. Without those commitments, prevention risks becoming yet another election pledge.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Roche unlocks new horizons for genomic research in Asia Pacific

Roche unlocks new horizons for genomic research in Asia Pacific

Health Industry Hub | November 9, 2026 |

Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]

More


News - Pharmaceuticals

'Unexpected and Surprising': Novartis’ Lp(a) setback raises tough questions for Amgen and Lilly - Professor Stephen Nicholls, Victorian Heart Hospital

‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly

Health Industry Hub | November 9, 2026 |

The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]

More


News - MedTech & Diagnostics

More public hospitals turn to same-day hip and knee surgery but recovery risks persist

More public hospitals turn to same-day hip and knee surgery, but key blind spots persist

Health Industry Hub | November 9, 2026 |

Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]

More


News - Pharmaceuticals

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

Health Industry Hub | November 9, 2026 |

The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]

More


This content is copyright protected. Please subscribe to gain access.